Drreddys Laboratories | RDY - PE价格收益

金融业

INR

INR 579.35B

现金及等价物

INR 15.37B

INR 32.13B

INR 301.98B

INR 167.57B

INR 77.34B

股息收益率

INR 0.66

INR 3.05B

INR 8.63B

INR 27.81K

EPS每股收益

INR 0.06

股本和储备

INR 380.46B

INR 43.04B

债务利息支出

INR 1.06B

INR 796M

INR 12.2B

INR 2.44B

INR 2.21B

INR 74.33B

INR 829M

普通股股本

INR 832.69M

19.25

INR 2B

INR 789.05M

销售和管理费用

INR 14.47B

INR 76.53B

贸易债权人

INR 22.36B

应收帐款人

INR 123.17B

	Pe	更改		日
ANI Pharmaceuticals	27.31		10.68	2026-03
Aurora Cannabis	23.27		0	2026-03
Bayer	3.4		8.75	2026-03
Cipla	23.56		4.18	2026-03
Corcept Therapeutics	113.58		71.67	2026-03
Drreddys Laboratories	19.25		0.98	2026-03
GlaxoSmithKline	14.87		3.72	2026-03
Hikma Pharmaceutical	10.43		3.72	2025-12
Lonza	34.34		2.58	2025-12
Novartis	20.17		2.32	2026-03
Pacira	38.58		14.1	2026-03
Phibro Animal Health	13.82		4.04	2025-12
Prestige Brands	15.31		3.1	2025-12
Richter Gedeon	10.77		2.94	2026-03
Sun Pharmaceuticals	39.44		5.7	2025-12
Supernus Pharmaceuticals	44.21		66.17	2026-03
Teva Pharmaceutical Industries	10.07		0.04	2026-03